What is Caverject used for? Caverject is used to treat erectile dysfunction (ED) in adult men by helping them achieve and maintain an erection firm enough for sexual intercourse when injected directly into the penis.

• It contains alprostadil, a synthetic version of prostaglandin E1, which acts locally to relax penile smooth muscle tissue.
• The medication addresses ED caused by physical issues such as vascular problems, diabetes, or nerve damage after prostate surgery.
• Doctors may prescribe it when oral ED medications like sildenafil fail or are not suitable due to health conditions.
• Caverject can produce an erection in men with various degrees of ED severity, including cases where blood flow is severely restricted.
• It is also sometimes used in clinical settings for diagnostic testing to evaluate the cause of impotence.
• The treatment targets the specific area of the penis rather than relying on systemic arousal signals.
• It provides a reliable option for men who need an on-demand solution independent of natural stimulation.

How does Caverject produce an erection? Caverject produces an erection by relaxing the smooth muscles inside the penis and dilating blood vessels, which allows increased blood flow into the erectile tissue (corpora cavernosa) to create and sustain firmness.

• Alprostadil binds to specific receptors on smooth muscle cells, triggering a cascade that reduces muscle tension.
• This relaxation opens up the penile arteries and trabecular spaces, enabling rapid inflow of arterial blood.
• At the same time, it helps trap blood by compressing veins against the tough outer layer (tunica albuginea).
• The process mimics the natural physiological response to sexual stimulation but occurs locally and independently.
• Erection develops quickly because the drug acts directly at the injection site without needing full-body circulation first.
• The effect is dose-dependent, meaning the injected amount influences the strength and duration of the response.
• Unlike oral medications, it bypasses the digestive system and liver for faster, more predictable local action.

How soon after injection does it start working? Caverject typically starts working within 5 to 20 minutes after proper intracavernosal injection, with most men achieving a usable erection in that window.

• Onset time varies slightly based on individual response, dose, and injection technique.
• Many users report noticeable firmness beginning as early as 5–10 minutes post-injection.
• The average time to full erection suitable for intercourse is around 10–15 minutes.
• Factors like proper site selection and avoiding scar tissue can speed up the onset.
• If no response occurs after 20–30 minutes, the dose may need adjustment under medical guidance.
• The rapid action makes it suitable for planned sexual activity with minimal waiting time.
• Unlike oral ED drugs that require 30–60 minutes or more, Caverject delivers quicker results directly at the target tissue.

How long does the erection typically last? The erection produced by Caverject usually lasts 30 minutes to 1 hour, long enough for satisfactory sexual intercourse, though it should not exceed 1 hour to minimize risk of complications.

• Duration depends on the injected dose, with lower doses often producing shorter but sufficient erections.
• Most men achieve an erection that remains firm for 45–60 minutes when using the recommended amount.
• The effect gradually subsides as alprostadil is metabolized locally in the penile tissue.
• Erections beyond 1 hour require medical attention to prevent tissue damage.
• Users are advised to seek help if rigidity persists over 4 hours (priapism risk).
• Proper dosing helps balance effective duration with safety for repeated use.
• The medication is designed for on-demand use, not continuous erection maintenance.

What is the recommended injection frequency? The recommended frequency for Caverject injections is no more than 3 times per week, with at least 24 hours between each dose to allow penile tissue to recover and reduce the risk of side effects.

• Limiting use to 3 times weekly helps prevent long-term issues like penile fibrosis or plaque formation.
• The 24-hour minimum interval gives smooth muscle and blood vessels time to rest after each injection.
• Overuse can increase the chance of pain, scarring, or reduced responsiveness over time.
• Clinical guidelines emphasize spacing doses to maintain tissue health during long-term treatment.
• Some men successfully use it 2–3 times weekly without problems when following instructions.
• Always start with the lowest effective dose to support safe frequency of use.
• Regular medical follow-up is important if injections become a frequent part of treatment.

Where is the injection administered? Caverject is administered by injecting directly into the side (dorso-lateral aspect) of the proximal third of the penis, alternating sides with each use to minimize tissue irritation and scarring.

• The injection site is typically 1/3 from the base of the penis, on the left or right side, avoiding the top (urethra), bottom (blood vessels), or midline.
• Proper placement targets the corpora cavernosa, the two spongy chambers that fill with blood to create an erection.
• Alternating sides (left then right, or vice versa) every injection helps distribute any minor trauma evenly across the tissue.
• Users should avoid injecting into visible veins, scars, or areas of curvature to reduce complications.
• The penis should be gently stretched and held steady during injection for accurate delivery into the erectile tissue.
• Correct site selection ensures the medication reaches the intended smooth muscle and vascular structures quickly.
• Training materials or diagrams from the product packaging guide precise location and technique.

What needle size is typically used? Caverject is typically used with a 27- to 30-gauge needle that is ½ inch (12–13 mm) long to allow shallow, comfortable, and effective intracavernosal delivery with minimal discomfort.

• A finer gauge (27–30) reduces pain and tissue trauma compared to thicker needles while still allowing smooth medication flow.
• The ½-inch length is sufficient to reach the corpora cavernosa without penetrating too deeply into other structures.
• Shorter needles help prevent accidental injection into deeper tissues or blood vessels.
• Many users find 30-gauge needles cause the least stinging or burning sensation during insertion.
• The needle attaches to a standard 1 mL insulin syringe or the pre-filled device if provided in some kits.
• Sterile, single-use needles are essential to avoid infection and ensure consistent performance.
• Proper needle disposal follows safe sharps protocols after each use.

Can Caverject help if oral ED medications fail? Yes, Caverject often helps achieve an erection when oral ED medications like sildenafil, tadalafil, or vardenafil fail, because it works directly on penile tissue rather than relying on systemic blood flow and nerve signals.

• It bypasses the need for intact nitric oxide pathways that oral PDE5 inhibitors depend on.
• Many men with vascular damage, diabetes, or post-prostatectomy nerve issues respond well to alprostadil injections.
• Clinical studies show higher success rates with intracavernosal therapy in severe or treatment-resistant ED cases.
• The local action delivers the drug exactly where needed, producing reliable results even with poor natural response.
• It serves as a second- or third-line option recommended by urologists when pills are ineffective or contraindicated.
• Effectiveness remains high regardless of psychological factors or timing with meals that can affect oral drugs.
• Switching to Caverject frequently restores confidence and sexual function for non-responders to tablets.

What are common local reactions after injection? Common local reactions after Caverject injection include mild to moderate penile pain at the injection site, redness, minor swelling, or small bruising, which usually resolve quickly without treatment.

• Penile pain is the most frequently reported side effect, often described as aching or burning lasting 5–30 minutes.
• Redness or warmth at the site occurs due to increased local blood flow and is typically temporary.
• Minor bruising or a small hematoma may appear if a tiny blood vessel is nicked during injection.
• These reactions tend to decrease in intensity with continued proper use and technique refinement.
• Applying gentle pressure after injection can help reduce bleeding or bruising.
• Most men tolerate these effects well, especially as they become familiar with the process.
• Persistent or severe pain should prompt dose adjustment or medical consultation.

What is priapism and how to handle it? Priapism is a prolonged, often painful erection lasting more than 4 hours that can occur rarely with Caverject; handle it as a medical emergency by seeking immediate professional care to prevent permanent penile damage.

• Priapism results from blood remaining trapped in the penis longer than intended, leading to tissue oxygen deprivation.
• Risk increases with higher doses, improper use, or certain medical conditions like sickle cell disease.
• Initial self-management may include applying ice packs, walking, or urinating to encourage detumescence.
• If the erection persists beyond 4 hours, contact a doctor or visit the emergency room right away.
• Medical treatment can include aspiration of blood, injection of reversal agents, or other interventions.
• Prompt action within the first few hours greatly reduces the chance of long-term erectile tissue scarring.
• Users should be educated on priapism signs and have a plan before starting treatment.

Is Caverject suitable for diagnostic testing? Yes, Caverject is suitable and commonly used for diagnostic testing to help determine the cause of erectile dysfunction by assessing penile vascular function and response to direct stimulation.

• Urologists often inject alprostadil to evaluate whether ED stems from vascular, neurological, or psychological issues.
• A good response (firm erection) typically indicates intact penile blood vessels and smooth muscle, pointing away from severe arterial problems.
• Poor or no response may suggest venous leakage, severe arterial insufficiency, or other structural issues requiring further tests like Doppler ultrasound.
• The test helps differentiate between organic and psychogenic causes, guiding appropriate treatment plans.
• It provides objective data on erectile capacity independent of patient arousal or partner interaction.
• Diagnostic doses are usually lower than therapeutic ones to minimize side effects during evaluation.
• Results from Caverject testing often influence decisions about oral therapies, injections, vacuum devices, or surgical options.

How should unused reconstituted solution be handled? Unused reconstituted Caverject solution should be discarded immediately after single use and never stored or reused, as it is intended for one-time administration only to maintain sterility and potency.

• Once mixed with the diluent, the solution is stable for only a short period and loses effectiveness quickly.
• Bacteriostatic water or the provided diluent does not preserve the medication indefinitely after reconstitution.
• Storing reconstituted solution increases the risk of bacterial contamination and potential infection at the injection site.
• Product labeling and medical guidelines explicitly state single-use only with no refrigeration or carry-over permitted.
• Dispose of any remaining liquid, syringe, and needle safely in a sharps container right after injection.
• Preparing only the exact prescribed dose helps avoid waste and ensures maximum safety.
• Always use a fresh vial for each injection to guarantee consistent results and minimize complications.

Are there conditions where Caverject should be avoided? Caverject should be avoided in several medical conditions to prevent serious complications, including hypersensitivity to alprostadil, conditions predisposing to priapism, penile fibrosis or deformity, penile implants, and certain blood disorders.

• Avoid use if allergic to alprostadil or any component, as severe reactions like anaphylaxis can occur.
• Conditions like sickle cell anemia, leukemia, multiple myeloma, or thrombocythemia increase priapism risk significantly.
• Existing penile fibrosis, Peyronie’s disease, or anatomical deformities may worsen with injections.
• Men with penile implants (prostheses) face higher chances of mechanical damage or infection.
• Anticoagulant therapy or bleeding disorders raise the risk of excessive bruising or hematoma.
• Recent penile trauma, infection, or urethritis requires complete healing before starting treatment.
• Always consult a healthcare provider to review personal medical history before use.

Does long-term use affect spontaneous erections? Long-term use of Caverject may improve spontaneous erections in some men over time due to potential vascular and tissue health benefits, though results vary and it is not guaranteed.

• Regular injections can enhance penile blood flow and oxygenation, potentially reversing some endothelial dysfunction.
• Studies suggest a subset of users experience gradual return of natural nocturnal or morning erections after months of consistent use.
• Improved tissue health from repeated vasodilation may reduce underlying vascular ED progression.
• Psychological confidence gained from reliable erections can reduce performance anxiety, aiding natural response.
• Not all men see this benefit; some require ongoing injections without spontaneous recovery.
• Positive changes, when they occur, are more common in milder ED cases or with early intervention.
• Long-term outcomes depend on underlying cause, adherence, and concurrent lifestyle factors like exercise and diet.

How is the powder prepared for injection? The Caverject powder is prepared for injection by reconstituting the lyophilized alprostadil with the provided sterile diluent (usually bacteriostatic water), gently mixing until fully dissolved, then drawing the prescribed dose into a syringe.

• Remove the vial caps and swab both the powder vial and diluent vial tops with alcohol.
• Use the syringe to withdraw the exact volume of diluent specified in the instructions.
• Slowly inject the diluent into the powder vial along the side wall to avoid foaming.
• Gently swirl or roll the vial between your hands until the powder completely dissolves; do not shake vigorously.
• Once clear and free of particles, draw the required dose (in mcg) back into the syringe.
• Remove air bubbles by tapping the syringe and pushing the plunger slightly.
• The solution should be used immediately after preparation for best potency and safety.